NCT04596033 2022-07-15TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyGenocea Biosciences, Inc.Phase 1 Terminated49 enrolled
NCT02280811 2017-09-06T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated CancersNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed12 enrolled 19 charts